| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
CAMP4 Therapeutics Corporation
13D/A
Amendment 3
CAMP · 13463J101
|
9.9% |
8/31/2026
Event 8/27/2026
|
|||
| 5AM Ventures VI, L.P. | 3.2% | ||||
| 5AM Partners VI, LLC | 3.2% | ||||
| 5AM Ventures VII, L.P. | 6.3% | ||||
| 5AM Partners VII, LLC | 6.3% | ||||
| 5AM Opportunities II, L.P. | 0.5% | ||||
| 5AM Opportunities II (GP), LLC | 0.5% | ||||
| Andrew J. Schwab | 9.9% | ||||
| Kush Parmar | 9.9% | ||||
|
Artiva Biotherapeutics, Inc.
13G/A
Amendment 1
ARTV · 04317A107
|
4.8% |
8/10/2026
Event 6/30/2026
|
|||
| 5AM Ventures VI, L.P. | 2.4% | ||||
| 5AM Partners VI, LLC | 2.4% | ||||
| 5AM Opportunities II, L.P. | 2.4% | ||||
| 5AM Opportunities II (GP), LLC | 2.4% | ||||
| Andrew J. Schwab | 4.8% | ||||
| Kush Parmar | 4.8% | ||||
|
CAMP4 Therapeutics Corporation
13D/A
Amendment 2
CAMP · 13463J101
|
9.9% |
8/5/2026
Event 8/3/2026
|
|||
| 5AM Ventures VI, L.P. | 4.2% | ||||
| 5AM Partners VI, LLC | 4.2% | ||||
| 5AM Ventures VII, L.P. | 5.3% | ||||
| 5AM Partners VII, LLC | 5.3% | ||||
| 5AM Opportunities II, L.P. | 0.5% | ||||
| 5AM Opportunities II (GP), LLC | 0.5% | ||||
| Andrew J. Schwab | 9.9% | ||||
| Kush Parmar | 9.9% | ||||
|
CAMP4 Therapeutics Corporation
13D/A
Amendment 1
CAMP · 13463J101
|
12.5% |
9/11/2025
Event 9/9/2025
|
|||
| 5AM Ventures VI, L.P. | 5.6% | ||||
| 5AM Partners VI, LLC | 5.6% | ||||
| 5AM Ventures VII, L.P. | 6.3% | ||||
| 5AM Partners VII, LLC | 6.3% | ||||
| 5AM Opportunities II, L.P. | 0.6% | ||||
| 5AM Opportunities II (GP), LLC | 0.6% | ||||
| Andrew J. Schwab | 12.5% | ||||
| Kush Parmar | 12.5% | ||||
|
Vor Biopharma Inc.
13D/A
Amendment 2
VOR · 929033108
|
3.5% |
7/9/2025
Event 7/8/2025
|
|||
| 5AM Ventures VI, L.P. | 2.6% | ||||
| 5AM Partners VI, LLC | 2.6% | ||||
| 5AM Opportunities I, L.P. | 1.0% | ||||
| 5AM Opportunities I (GP), LLC | 1.0% | ||||
| Andrew J. Schwab | 3.5% | ||||
| Kush Parmar | 3.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.